The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma: Is Cure Possible?
Abstract
OBJECTIVE: To determine long-term survival after pancreatoduodenectomy for pancreatic ductal adenocarcinoma and to identify clinical factors associated with long-term survival. SUMMARY BACKGROUND DATA: The prognosis for long-term survival even after potentially curative resection for pancreatic adenocarcinoma is thought to be poor. Clinical factors determining short-term survival after pancreatic resection are well studied, but prognostic factors predicting long-term survival with a potential for cure are poorly understood. METHODS: A case-control study was conducted of 357 patients who underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma between 1981 and 2001. Histologic specimens were reanalyzed to confirm diagnosis. Follow-up was at least 5 years or until death. RESULTS: There was an improved survival throughout the observation period (P = 0.004). We found 62 actual 5-year survivors of whom 21 patients survived greater than 10 years, for a 5- and 10-year survival rate of 18% and 13%, respectively. Cohort analysis comparing patients with short-term (<5 years, n = 295) and long-term (> or =5 years, n = 62) survival showed that more advanced disease (greatest tumor diameter, lymph node metastasis) and decreased serum albumin concentration were unfavorable for long-term survival (all P < 0.05). In contrast, the extent of resection and more aggressive histologic features did not correlate with long-term survival (all P > 0.05). En-bloc resection (P = 0.005) but not resection margin status (P > 0.05) was associated with long-term survival. Adjuvant chemoradiation therapy did not significantly influence long-term survival. Multivariate analysis identified lymph node status (OR 0.36, 95% CI 0.14-0.89, P = 0.03) as a prognostic factor for long-term survival. Five-year survival was no guarantee of cure because 16% of this subset died of pancreatic cancer up to 7.8 years after operation. CONCLUSION: Pancreatoduodenectomy for adenocarcinoma in the head of pancreas can provide long-term survival in a subset of patients, particularly in the absence of lymph node metastasis. One of 8 patients can achieve 10-year survival with a potential for cure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,489
Wagner, M., Redaelli, C., Lietz, M., Seiler, C. A., Friess, H., & Büchler, M. W. (2004) · British Journal of Surgery · doi:10.1002/bjs.4484 · Cited by 844
Conlon, K. C., Klimstra, D. S., & Brennan, M. F. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00007 · Cited by 709
Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?
Nitecki, S. S., Sarr, M. G., Colby, T. V., & van Heerden, J. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199501000-00007 · Cited by 586
Self-citationLim, J. E., Chien, M. W., & Earle, C. C. (2003) · Annals of Surgery · doi:10.1097/00000658-200301000-00011 · Cited by 586
National Failure to Operate on Early Stage Pancreatic Cancer
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Stewart, A. K., Winchester, D. P., & Talamonti, M. S. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180691579 · Cited by 554
Richter, A., Niedergethmann, M., Sturm, J. W., Lorenz, D., Post, S., & Trede, M. (2003) · World Journal of Surgery · doi:10.1007/s00268-002-6659-z · Cited by 401
Pancreaticoduodenectomy: A 20-Year Experience in 516 Patients
Schmidt, C. M. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.7.718 · Cited by 390
Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors1
Cleary, S. P., Gryfe, R., Guindi, M., Greig, P., Smith, L., Mackenzie, R., Strasberg, S., Hanna, S., Taylor, B., Langer, B., et al. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.01.008 · Cited by 323
Howard, T. J., Krug, J. E., Yu, J., Zyromski, N. J., Schmidt, C. M., Jacobson, L. E., Madura, J. A., Wiebke, E. A., & Lillemoe, K. D. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.09.008 · Cited by 319
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up
Riall, T. S., Cameron, J. L., Lillemoe, K. D., Winter, J. M., Campbell, K. A., Hruban, R. H., Chang, D., & Yeo, C. J. (2006) · Surgery · doi:10.1016/j.surg.2006.04.006 · Cited by 246
Analysis of Long-term Survivors After Surgical Resection for Pancreatic Cancer
Han, S.-S., Jang, J.-Y., Kim, S.-W., Kim, W.-H., Lee, K. U., & Park, Y.-H. (2006) · Pancreas · doi:10.1097/01.mpa.0000202953.87740.93 · Cited by 162
Allison, D. C., Piantadosi, S., Hruban, R. H., Dooley, W. C., Fishman, E. K., Yeo, C. J., Lillemoe, K. D., Pitt, H. A., Lin, P., & Cameron, J. L. (1998) · Journal of Surgical Oncology · Cited by 123
Pancreatic Cancer in the General Population: Improvements in Survival Over the Last Decade
Riall, T. S., Nealon, W. H., Goodwin, J. S., Zhang, D., Kuo, Y., Townsend, C. M., & Freeman, J. L. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.010 · Cited by 116
Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma
Jeekel, H. J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000134635.47013.71 · Cited by 60
Cited by
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
van der Gaag, N. A., Rauws, E. A. J., van Eijck, C. H. J., Bruno, M. J., van der Harst, E., Kubben, F. J. G. M., Gerritsen, J. J. G. M., Greve, J. W., Gerhards, M. F., de Hingh, I. H. J. T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903230 · Cited by 1,049
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
“Long-term survival can be achieved by resecting small non-metastatic PCs, 59 60 particularly if margins are negative for invasive PC (R0 resection).”
BackgroundGroot, V. P., Rezaee, N., Wu, W., Cameron, J. L., Fishman, E. K., Hruban, R. H., Weiss, M. J., Zheng, L., Wolfgang, C. L., & He, J. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002234 · Cited by 757
Challenges in diagnosis of pancreatic cancer
Zhang, L., Sanagapalli, S., & Stoita, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2047 · Cited by 588
Self-citationLong-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Katz, M. H. G., Wang, H., Fleming, J. B., Sun, C. C., Hwang, R. F., Wolff, R. A., Varadhachary, G., Abbruzzese, J. L., Crane, C. H., Krishnan, S., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0295-2 · Cited by 480
Metadata
- Authors
- Schnelldorfer, T., Ware, A. L., Sarr, M. G., Smyrk, T. C., Zhang, L., Qin, R., Gullerud, R. E., Donohue, J. H., Nagorney, D. M., & Farnell, M. B.
- Venue
- Annals of Surgery
- Published
- 2008-03
- Volume
- 247
- Issue
- 3
- Pages
- 456-462
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2113662908
- Cited by
- 458
- References
- 18
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.